Results 11 to 20 of about 3,675 (156)

Clinical Outcomes of Micropulse Transscleral Cyclophotocoagulation in Patients with a History of Keratoplasty [PDF]

Journal of Ophthalmology, 2020
Purpose. To examine the surgical outcomes and graft conditions in patients receiving micropulse transscleral cyclophotocoagulation (MP-TSCPC) to treat post-keratoplasty ocular hypertension. Methods. This retrospective observational study included 30 eyes
Jun Hui Lee, Vivian Vu, Gabriel Lazcano-Gomez, Katherine Han, Pukkapol Suvannachart, Jennifer Rose-Nussbaumer, Julie Schallhorn, David Hwang, Ying Han   +8 more
doaj   +10 more sources

Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation [PDF]

Journal of Clinical Medicine, 2022
Background: Early studies have shown that micropulse transscleral cyclophotocoagulation (MP-TSCPC) might be an effective and safe treatment option for lowering intraocular pressure (IOP). These studies were, however, somewhat limited, in particular by their retrospective nature and the length of follow-up. Therefore, we assessed the efficacy and safety
Wishal D Ramdas, Roger C W Wolfs, Jan Pals   +2 more
exaly   +7 more sources

Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uveitic Glaucoma [PDF]

Ophthalmology and Therapy
Purpose To report a case series of patients with uveitic glaucoma who were treated with micropulse transscleral cyclophotocoagulation (mpCPC). Methods This retrospective case series consists of patients from the University of Colorado Sue Anschutz ...
Julia L. Xia, Monica K. Ertel, Amit K. Reddy, Alan G. Palestine, Arthur J. Stanley, Cara E. Capitena Young, Mina B. Pantcheva   +6 more
doaj   +4 more sources

MicroPulse Transscleral Laser Therapy Demonstrates Similar Efficacy with a Superior and More Favorable Safety Profile Compared to Continuous-Wave Transscleral Cyclophotocoagulation

Journal of Ophthalmology, 2022
Purpose. The aim of this study was to compare effectiveness and safety of MicroPulse transscleral laser therapy (MP-TLT) using the original MicroPulse P3® device and continuous-wave transscleral cyclophotocoagulation (CW-TSCPC) using the G-Probe® device ...
Enrico Bernardi, Marc Töteberg-Harms
doaj   +3 more sources

Micropulse transscleral cyclophotocoagulation versus slow coagulation in refractory glaucoma: study protocol of a randomized clinical trial [PDF]

Trials
Background Traditional continuous diode laser transscleral cyclophotocoagulation (TCW-TSCPC) has been used for decades to reduce intraocular pressure (IOP) by decreasing aqueous humor (AH) production in patients with glaucoma.
César Rodrigues de Lima Neto, José Paulo de Cabral Vasconcellos, Samuel Goulart Nacacio E. Silva, Vital Paulino Costa   +3 more
doaj   +3 more sources

Micropulse transscleral cyclophotocoagulation for the treatment of glaucoma [PDF]

Российский офтальмологический журнал, 2020
Because of the unpredictable hypotensive effect and serious complications during continuous-wave cyclophotocoagulation (CW-CPC), the use of this method in the treatment of glaucoma is limited. Therefore, a new technique was developed, known as micropulse
N. S. Khodzhaev, A. V. Sidorova, A. V. Starostina, M. A. Eliseeva   +3 more
doaj   +4 more sources

MicroPulse Transscleral Cyclophotocoagulation for Early to Moderate Glaucoma: A Case Series of 11 Eyes with One-Year Follow-Up and Literature Review [PDF]

Clinical Ophthalmology
Liu Li, Yingjie Li Department of Ophthalmology, Nanchang First Hospital, Nanchang, Jiangxi Province, 330008, People’s Republic of ChinaCorrespondence: Yingjie Li, Department of Ophthalmology, Nanchang First Hospital, Nanchang, 330008, People’s Republic ...
Li L, Li Y
doaj   +4 more sources

Micropulse transscleral cyclophotocoagulation (MP-CPC): efficacy endpoints for the treatment of refractory paediatric glaucoma - a retrospective case-series [PDF]

BMC Ophthalmology
Background This study evaluates the efficacy and safety of micropulse transscleral cyclophotocoagulation (MP-CPC) in paediatric patients. Methods This retrospective case-series recruited 44 eyes for glaucoma patients who were younger than 17 years and ...
Nasser Balbaid, Mohammed AlJodai, Ghadeer Fairaq, Maram AlEnzi, Sami AlShahwan   +4 more
doaj   +3 more sources

Efficacy and Safety of Micropulse Transscleral Cyclophotocoagulation Use in Refractory Glaucoma Patients [PDF]

Majalah Kedokteran Bandung, 2022
Glaucoma is the leading cause of irreversible blindness worldwide. Micropulse Transscleral Cyclophotocoagulation (MP-TSCPC) is a new method for treatment for refractory glaucoma with lesser complications than coventional TSCPC.
Elsa Gustianty, R Maula Rifada
exaly   +9 more sources

Micropulse vs. continuous wave transscleral cyclophotocoagulation in neovascular glaucoma [PDF]

Experimental and Therapeutic Medicine, 2022
Neovascular glaucoma (NVG) is a refractory form of glaucoma, associated with important morbidity, for which no consensus exists regarding the optimal choice of therapy. The primary aim of our study was to compare the performances of micropulse transscleral cyclophotocoagulation (MP-TSCPC) and continuous wave transscleral cyclophotocoagulation (CW-TSCPC)
Zemba, Mihail, Dumitrescu, Otilia-Maria, Vaida, Florin, Dimirache, Elena-Andreea, Pistolea, Iulia, Stamate, Alina, Burcea, Marian, Branisteanu, Daniel, Balta, Florian, Barac, Ileana   +9 more
openaire   +6 more sources